Headquarters
320 SOQUEL WAY, SUNNYVALE, CA 94085-4101, US
SUNNYVALE, CA, US
BIOCARDIA, INC.
From the company
BioCardia, Inc. is developing cellular and cell-derived therapeutics for the treatment of unmet cardiovascular and pulmonary diseases. Its lead program is the CardiAMP autologous mononuclear cell therapy for ischemic heart failure with reduced ejection fraction (HFrEF), manufactured at the patient's bedside using the proprietary CardiAMP cell processing system and delivered via a catheter-based minimally invasive approach. Its allogeneic mesenchymal stem cell platform is advanced as CardiALLO for heart failure and PulmALLO for acute respiratory distress
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.